168 related articles for article (PubMed ID: 22808283)
1. Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.
Jembere N; Campitelli MA; Sherman M; Feld JJ; Lou W; Peacock S; Yoshida E; Krahn MD; Earle C; Thein HH
PLoS One; 2012; 7(7):e40917. PubMed ID: 22808283
[TBL] [Abstract][Full Text] [Related]
2. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study.
Anyiwe K; Qiao Y; De P; Yoshida EM; Earle CC; Thein HH
Liver Int; 2016 Jun; 36(6):902-10. PubMed ID: 26455359
[TBL] [Abstract][Full Text] [Related]
3. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):861-866. PubMed ID: 31953780
[TBL] [Abstract][Full Text] [Related]
4. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
[TBL] [Abstract][Full Text] [Related]
5. Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.
Thein HH; Anyiwe K; Jembere N; Yu B; De P; Earle CC
PLoS One; 2017; 12(10):e0186350. PubMed ID: 29020052
[TBL] [Abstract][Full Text] [Related]
6. The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.
Sellers CM; Uhlig J; Ludwig JM; Taddei T; Stein SM; Lim JK; Kim HS
Cancer Med; 2019 Oct; 8(13):5948-5958. PubMed ID: 31436905
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
8. Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
De Toni EN; Schlesinger-Raab A; Fuchs M; Schepp W; Ehmer U; Geisler F; Ricke J; Paprottka P; Friess H; Werner J; Gerbes AL; Mayerle J; Engel J
Gut; 2020 Jan; 69(1):168-176. PubMed ID: 30878947
[TBL] [Abstract][Full Text] [Related]
9. Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer.
Abdel-Rahman O
J Comp Eff Res; 2020 Dec; 9(17):1233-1241. PubMed ID: 33275039
[No Abstract] [Full Text] [Related]
10. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Kumachev A; Trudeau ME; Chan KK
Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
[TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
12. Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.
Hester CA; Karbhari N; Rich NE; Augustine M; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Singal AG; Yopp AC
Cancer; 2019 Oct; 125(19):3428-3436. PubMed ID: 31299089
[TBL] [Abstract][Full Text] [Related]
13. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
14. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
16. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
17. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis.
Chaiteerakij R; Chattieng P; Choi J; Pinchareon N; Thanapirom K; Geratikornsupuk N
Ann Hepatol; 2017; 16(3):421-429. PubMed ID: 28425412
[TBL] [Abstract][Full Text] [Related]
19. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
20. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]